548 related articles for article (PubMed ID: 29440068)
21. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
White NM; Khella HW; Grigull J; Adzovic S; Youssef YM; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Evans AJ; Gabril M; Yousef GM
Br J Cancer; 2011 Nov; 105(11):1741-9. PubMed ID: 22033272
[TBL] [Abstract][Full Text] [Related]
22. miR-30b-5p up-regulation related to the dismal prognosis for patients with renal cell cancer.
Zhang C; Pan X; Peng X; Liu K; Wang J; Zhao L; Chen X; Huang G; Li H; Ye J; Lai Y
J Clin Lab Anal; 2021 Feb; 35(2):e23599. PubMed ID: 33247622
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
[TBL] [Abstract][Full Text] [Related]
25. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
[TBL] [Abstract][Full Text] [Related]
26. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L
Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery.
Li H; Pan X; Gui Y; Quan J; Li Z; Zhao L; Guan X; Xu J; Xu W; Lai Y
Cancer Biomark; 2019; 24(2):153-158. PubMed ID: 30689558
[TBL] [Abstract][Full Text] [Related]
28. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
29. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs.
Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679
[TBL] [Abstract][Full Text] [Related]
30. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
31. Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence.
Zhang J; Ye Y; Chang DW; Lin SH; Huang M; Tannir NM; Matin S; Karam JA; Wood CG; Chen ZN; Wu X
Am J Pathol; 2018 Nov; 188(11):2487-2496. PubMed ID: 30201497
[TBL] [Abstract][Full Text] [Related]
32. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
33. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
34. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
35. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
[TBL] [Abstract][Full Text] [Related]
36. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.
Gowrishankar B; Ibragimova I; Zhou Y; Slifker MJ; Devarajan K; Al-Saleem T; Uzzo RG; Cairns P
Cancer Biol Ther; 2014 Mar; 15(3):329-41. PubMed ID: 24351440
[TBL] [Abstract][Full Text] [Related]
39. A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.
Ge YZ; Wu R; Xin H; Zhu M; Lu TZ; Liu H; Xu Z; Yu P; Zhao YC; Li MH; Hu ZK; Zhao Y; Zhong B; Xu X; Zhou LH; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1291-9. PubMed ID: 25633718
[TBL] [Abstract][Full Text] [Related]
40. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
